lobenzarit has been researched along with Cancer of Prostate in 1 studies
lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd
Excerpt | Relevance | Reference |
---|---|---|
"PBRM1 is a tumor promoter in prostate cancer, contributing to migratory and immunosuppressive phenotypes." | 1.72 | Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening. ( Blau, ME; Bursch, KL; Dykhuizen, EC; Fenske, TG; Goetz, CJ; Jensen, DR; Nuñez, R; Olp, MD; Ordonez-Rubiano, SC; Peterson, FC; Roach, MK; Shishodia, S; Smith, BC; Strohmier, BP; Volkman, BF, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Shishodia, S | 1 |
Nuñez, R | 1 |
Strohmier, BP | 1 |
Bursch, KL | 1 |
Goetz, CJ | 1 |
Olp, MD | 1 |
Jensen, DR | 1 |
Fenske, TG | 1 |
Ordonez-Rubiano, SC | 1 |
Blau, ME | 1 |
Roach, MK | 1 |
Peterson, FC | 1 |
Volkman, BF | 1 |
Dykhuizen, EC | 1 |
Smith, BC | 1 |
1 other study available for lobenzarit and Cancer of Prostate
Article | Year |
---|---|
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening.
Topics: Carcinogens; Chromatin; DNA Helicases; DNA-Binding Proteins; Histones; Humans; Male; Nuclear Protein | 2022 |